VOYA Investment Management
EVH icon

VOYA Investment Management’s Evolent Health EVH Stock Holding History

VOYA Investment Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.9K Sell
21,002
-686
-3% -$2.18K ﹤0.01% 2281
2025
Q4 		$86.8K Hold
21,688
– – ﹤0.01% 2281
2025
Q3 		$183K Sell
21,688
-10,521
-33% -$102K ﹤0.01% 2203
2025
Q2 		$363K Buy
32,209
+879
+3% +$8.07K ﹤0.01% 2046
2025
Q1 		$297K Sell
31,330
-3,466
-10% -$35K ﹤0.01% 2128
2024
Q4 		$391K Sell
34,796
-2,766
-7% -$48.6K ﹤0.01% 2055
2024
Q3 		$1.06M Sell
37,562
-779
-2% -$20.1K ﹤0.01% 1607
2024
Q2 		$733K Sell
38,341
-504,862
-93% -$12.9M ﹤0.01% 1801
2024
Q1 		$17.8M Buy
543,203
+33,611
+7% +$1.07M 0.02% 580
2023
Q4 		$16.8M Buy
509,592
+3,003
+0.6% +$85K 0.02% 572
2023
Q3 		$13.8M Sell
506,589
-182,778
-27% -$5.08M 0.02% 604
2023
Q2 		$20.9M Sell
689,367
-35,630
-5% -$1.15M 0.02% 504
2023
Q1 		$23.5M Buy
724,997
+144,999
+25% +$4.59M 0.03% 496
2022
Q4 		$16.3M Buy
579,998
+304,410
+110% +$8.73M 0.02% 584
2022
Q3 		$9.9M Buy
275,588
+244,550
+788% +$8.62M 0.01% 711
2022
Q2 		$953K Hold
31,038
– – ﹤0.01% 1434
2022
Q1 		$1M Buy
31,038
+291
+0.9% +$7.62K ﹤0.01% 1471
2021
Q4 		$850K Sell
30,747
-258
-0.8% -$7.4K ﹤0.01% 1655
2021
Q3 		$961K Hold
31,005
– – ﹤0.01% 1596
2021
Q2 		$655K Sell
31,005
-1,960
-6% -$39.3K ﹤0.01% 1925
2021
Q1 		$666K Sell
32,965
-63
-0.2% -$1.2K ﹤0.01% 1854
2020
Q4 		$529K Buy
33,028
+6,923
+27% +$91.5K ﹤0.01% 1887
2020
Q3 		$324K Sell
26,105
-720,540
-97% -$8.47M ﹤0.01% 1899
2020
Q2 		$5.32M Sell
746,645
-104,624
-12% -$701K 0.01% 725
2020
Q1 		$4.62M Buy
851,269
+815,282
+2,265% +$7.28M 0.01% 708
2019
Q4 		$326K Buy
35,987
+7,193
+25% +$58.4K ﹤0.01% 2128
2019
Q3 		$207K Hold
28,794
– – ﹤0.01% 2231
2019
Q2 		$229K Buy
28,794
+1,846
+7% +$21.9K ﹤0.01% 2229
2019
Q1 		$339K Sell
26,948
-934
-3% -$14.8K ﹤0.01% 1991
2018
Q4 		$556K Buy
27,882
+1,538
+6% +$35.6K ﹤0.01% 1651
2018
Q3 		$748K Hold
26,344
– – ﹤0.01% 1591
2018
Q2 		$555K Buy
26,344
+1,858
+8% +$35.2K ﹤0.01% 1753
2018
Q1 		$349K Hold
24,486
– – ﹤0.01% 2015
2017
Q4 		$301K Buy
24,486
+1,777
+8% +$25.1K ﹤0.01% 2136
2017
Q3 		$404K Buy
22,709
+5,061
+29% +$104K ﹤0.01% 1997
2017
Q2 		$447K Buy
+17,648
New +$424K ﹤0.01% 1911

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management's EVH Position: Q1 2026 in Review

VOYA Investment Management reduced its Evolent Health (EVH) stake by 3.2% in Q1 2026, selling an estimated $2.18K and leaving 21,002 shares worth $47.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2281.

VOYA Investment Management first reported a position in EVH in Q2 2017 and has held it in 36 quarters since. The position peaked at $23.5M in Q1 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • VOYA Investment Management held 21,002 shares of Evolent Health worth $47.9K as of Q1 2026.
  • VOYA Investment Management sold 686 Evolent Health shares in Q1 2026, an estimated $2.18K.
  • Evolent Health made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2281 holding.
  • VOYA Investment Management first reported a position in Evolent Health in Q2 2017 and has held it in 36 quarters since.
  • VOYA Investment Management's Evolent Health position peaked at $23.5M in Q1 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.